BCL6 and diffuse large B-cell lymphoma: Only MYC/BCL2 rearranged DLBCL showed a distinctive GEP signature, whereas concurrent MYC/BCL6 rearranged DLBCL did not show DEGs compared with MYC rearranged DLBCL or the remaining DLBCL patients.